Literature DB >> 1557928

Relative efficacy of two acellular pertussis vaccines during three years of passive surveillance.

J Storsaeter1, P Olin.   

Abstract

Prolonged unblinded passive surveillance of the trial cohort from the Swedish 1986-87 pertussis vaccine efficacy trial indicates that a two-component vaccine, containing pertussis toxoid and filamentous haemagglutinin, provided better long-term protection against pertussis than a monocomponent pertussis toxoid vaccine. The relative risk (RR) for culture-confirmed pertussis was 1.5 (95% confidence interval (CI) 1.0-2.4), and RR for pertussis according to parents' diagnoses was also 1.5 (95% CI 1.1-2.1), for the monocomponent vaccine compared with the two-component vaccine.

Mesh：

Substances：

Year:  1992        PMID： 1557928     DOI： 10.1016/0264-410x(92)90002-2

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


  13 in total

1.  Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programs.

Authors:  Hans O Hallander; Abdolreza Advani; Declan Donnelly; Lennart Gustafsson; Rose-Marie Carlsson
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

Review 2.  Prevention of pertussis: An unresolved problem.

Authors:  Susanna Esposito; Nicola Principi
Journal:  Hum Vaccin Immunother       Date:  2018-07-24       Impact factor: 3.452

Review 3.  Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Authors:  Seema Mattoo; James D Cherry
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

4.  Polymerase chain reaction assay for pertussis: simultaneous detection and discrimination of Bordetella pertussis and Bordetella parapertussis.

Authors:  A van der Zee; C Agterberg; M Peeters; J Schellekens; F R Mooi
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

Review 5.  Pertussis vaccines--1993.

Authors:  H J Schmitt; S Wagner
Journal:  Eur J Pediatr       Date:  1993-06       Impact factor: 3.183

6.  Antibody-mediated neutralization of pertussis toxin-induced mitogenicity of human peripheral blood mononuclear cells.

Authors:  Scott H Millen; David I Bernstein; Beverly Connelly; Joel I Ward; Swei-Ju Chang; Alison A Weiss
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

Review 7.  Pertussis.

Authors:  Giovanni Gabutti; Chiara Azzari; Paolo Bonanni; Rosa Prato; Alberto E Tozzi; Alessandro Zanetti; Gianvincenzo Zuccotti
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

8.  Evidence of Bordetella pertussis infection in vaccinated 1-year-old Danish children.

Authors:  Marie-Louise von Linstow; Peter Lotko Pontoppidan; Carl-Heinz Wirsing von König; James D Cherry; Birthe Hogh
Journal:  Eur J Pediatr       Date:  2010-04-08       Impact factor: 3.183

9.  Serum antibodies to the components of diphtheria-tetanus-pertussis vaccine in Polish children related to vaccination status.

Authors:  E Torbicka; T Lagergård; B Trollfors
Journal:  Infection       Date:  1995 Jul-Aug       Impact factor: 3.553

Review 10.  Acellular Pertussis Vaccine Components: Today and Tomorrow.

Authors:  Kalyan K Dewan; Bodo Linz; Susan E DeRocco; Eric T Harvill
Journal:  Vaccines (Basel)       Date:  2020-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.